当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第26期
编号:185543
Lp(a)、UA、Hcy、TG及HDL-C在不同严重程度冠心病患者中的应用价值
http://www.100md.com 2021年3月27日 中国医学创新 2021年第26期
同型半胱氨酸,尿酸
     杨贤慧 钟伟传 刘爱胜 刘国栋 凌秀婷

    【关键词】 脂蛋白a 尿酸 同型半胱氨酸 高密度脂蛋白胆固醇 冠心病

    [Abstract] Objective: To investigate the application value of lipoprotein a [Lp (a)], serum uric acid (UA), homocysteine (Hcy), triglyceride (TG) and high density lipoprotein cholesterol (HDL-C) in patients with different severity of coronary heart disease (CHD), so as to provide reference for the prevention, diagnosis and treatment of clinical CHD. Method: A total of 193 patients diagnosed with CHD from the outpatient or inpatient department of Cardiology of our hospital from May 2018 to June 2020 were selected as the CHD group, including 57 patients with mild symptoms, 92 patients with moderate symptoms and 44 patients with severe symptoms, 120 non CHD patients who came to the physical examination center of our hospital for physical examination in the same period were selected as the control group. The levels of Lp (a), UA, Hcy, TG and HDL-C in serum were detected, the detection results were statistically analyzed. Result: Lp (a) ......

您现在查看是摘要页,全文长 11365 字符